Virtus KAR Health Sciences Inst
Summary Prospectus
Document/cf6b8f88bf2e672383e156cd4ece7d31.msdoc?key=8e4aae5472d794c04c8d626a6392f8dad15671ad50f836cb
#
|
Prospectus
Document/05e399965df42581e55d5517fcf896a9.msdoc?key=8e4aae5472d794c04c8d626a6392f8dad15671ad50f836cb
#
|
Annual Report
Document/12a9db6bfb476f83bcdfa9ad95b70512.msdoc?key=8e4aae5472d794c04c8d626a6392f8dad15671ad50f836cb
#
|
Semi-Annual Report
Document/bc8e1518cc5ff28f6053c4c6853bb94c.msdoc?key=8e4aae5472d794c04c8d626a6392f8dad15671ad50f836cb
#
|
SAI
Document/218ac678bdbbb3a9629495c61164d1f0.msdoc?key=8e4aae5472d794c04c8d626a6392f8dad15671ad50f836cb
#
|
|
Objective and Strategy
GetObjectiveStrategy.aspx?InvestmentId=F00000UKS2&InvestmentType=1&clientid=schwab&key=84b36f1bf3830e07
Supplement To Prospectus
[3/25/2024]
(HTM)
Document/48930ea4cb16494cd1079329a9bfce61.msdoc?key=8e4aae5472d794c04c8d626a6392f8dad15671ad50f836cb
#
Supplement To Prospectus
[12/29/2023]
(HTM)
Document/e37163bfc9619fa3ce859135323de7fb.msdoc?key=8e4aae5472d794c04c8d626a6392f8dad15671ad50f836cb
#
Supplement to SAI
[3/25/2024]
(HTM)
Document/84fa02e11d6c3bb82532b37a9469ef32.msdoc?key=8e4aae5472d794c04c8d626a6392f8dad15671ad50f836cb
#
Link to Prospectus Table of Contents
Link to Statement of Additional Information Table of Contents
Back To TOC: Prospectus
Back To TOC: SAI